Last reviewed · How we verify

NCT04152460

Clinical Assessment of Preheated Versus Conventional Bulk Fill Resin Composite

Status unknown NA Last updated 16 February 2021
What this trial tests

NA trial testing Viscalor Bulk (VOCO,Cuxhaven) in Clinical Significance of Thermo-Viscous Composite in 54 participants. Status unknown.

Timeline
1 May 2020
Primary endpoint
1 May 2021
1 June 2021

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment54
Start date1 May 2020
Primary completion1 May 2021
Estimated completion1 June 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 59, any sex, with Clinical Significance of Thermo-Viscous Composite. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Randomized clinical trial to evaluate the clinical assessment of thermo-viscous versus conventional bulk fill resin composite in proximal compound posterior teeth.The null hypothesis is that there is no difference between thermo-viscous and conventional bulk fill resin composite.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04152460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing